Greater Manchester Transport Innovation Fund

REGENT Announces Strategic Investment from Yamato Holdings

Retrieved on: 
Tuesday, March 28, 2023

North Kingstown, R.I., March 28, 2023 (GLOBE NEWSWIRE) -- REGENT, creators of the category defining all-electric seagliders that connect coastal ports at speeds up to 180 MPH, today announced a strategic investment from Yamato Holdings, Japan’s largest parcel delivery and logistics company.

Key Points: 
  • North Kingstown, R.I., March 28, 2023 (GLOBE NEWSWIRE) -- REGENT, creators of the category defining all-electric seagliders that connect coastal ports at speeds up to 180 MPH, today announced a strategic investment from Yamato Holdings, Japan’s largest parcel delivery and logistics company.
  • The investment signifies the expansion of seaglider applications into a new vertical, further supports REGENT’s entry into the Japanese market following a recent investment by Japan Airlines Innovation Fund, and brings the company’s total investment to over $50 million.
  • ​​“We see a unique opportunity and potential in REGENT seagliders which shall dramatically transform how logistics services are to be offered,” says Takaaki Adachi, Senior Manager to Innovation at Yamato Holdings (Executive Officer to Innovation at Yamato Transport).
  • In addition to the investment, REGENT and Yamato Holdings plan to work together to bring seagliders to logistics markets in Japan and around the world.

Orasis Pharmaceuticals Submits New Drug Application for Investigational Novel Eye Drop Candidate, CSF-1, for the Treatment of Presbyopia

Retrieved on: 
Tuesday, January 3, 2023

PONTE VEDRA, Fla., Jan. 3, 2023 /PRNewswire/ -- Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near vision for people with presbyopia, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for investigational CSF-1 (low dose pilocarpine hydrochloride 0.4%).

Key Points: 
  • CSF-1 is a novel corrective eye drop candidate being investigated for the treatment of presbyopia.
  • There are almost two billion people globally and more than 120 million people in the U.S. living with presbyopia.
  • Many existing treatment options can be either cumbersome or invasive, presenting a significant unmet need for quality-of-life improvement for people with presbyopia.
  • Orasis Pharmaceuticals is developing CSF-1, a corrective eye drop for the treatment of presbyopia.

Cresset Partners Hires Shari Young Lewis as Managing Director, Private Funds Group

Retrieved on: 
Tuesday, November 29, 2022

CHICAGO, Nov. 29, 2022 /PRNewswire/ -- Cresset Partners announced today that it has hired Shari Young Lewis as Managing Director, Private Funds Group.

Key Points: 
  • CHICAGO, Nov. 29, 2022 /PRNewswire/ -- Cresset Partners announced today that it has hired Shari Young Lewis as Managing Director, Private Funds Group.
  • Cresset Partners has quickly become a leader in the private funds space, and I look forward to contributing to that growth," Lewis said.
  • In June of 2022, Cresset Partners named Kevin O'Donnell Executive Managing Director of its Private Funds Group, encompassing private equity, private credit, and venture capital.
  • Cresset Partners is a private investment firm focused on providing its investors with direct access to investment opportunities in private companies, real estate, private credit, private equity secondaries, and venture capital.

National Kidney Foundation Innovation Fund Announces Investment in 34 Lives

Retrieved on: 
Monday, October 24, 2022

NEW YORK, Oct. 24, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) Innovation Fund, the philanthropic impact investment program of NKF, today announced a new investment that could have a major impact in kidney transplantation in the United States. 34 Lives, formerly Renovera, has received an investment from NKF to accelerate the development of a proprietary process to rehabilitate donated kidneys for transplantation.

Key Points: 
  • NEW YORK, Oct. 24, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) Innovation Fund, the philanthropic impact investment program of NKF, today announced a new investment that could have a major impact in kidney transplantation in the United States.
  • 34 Lives, formerly Renovera, has received an investment from NKF to accelerate the development of a proprietary process to rehabilitate donated kidneys for transplantation.
  • "Every day in the U.S., approximately 34 lives are lost waiting for an organ transplant," explained Chris Jaynes, founder and chief executive officer of 34 Lives.
  • For more information about the NKF Innovation Fund, visit kidney.org/innovationfund
    To learn more about kidney disease and how to maintain optimal kidney health, visit www.kidney.org/ .

First Hydrogen Expands into European Union

Retrieved on: 
Wednesday, September 28, 2022

Vancouver, British Columbia--(Newsfile Corp. - September 28, 2022) - First Hydrogen Corp. (TSXV: FHYD) (OTC Pink: FHYDF) (FSE: FIT) ("FIRST HYDROGEN" or the "Company") is pleased to announce that it is advancing its European Union strategy with expansion in key European countries.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 28, 2022) - First Hydrogen Corp. (TSXV: FHYD) (OTC Pink: FHYDF) (FSE: FIT) ("FIRST HYDROGEN" or the "Company") is pleased to announce that it is advancing its European Union strategy with expansion in key European countries.
  • In order to ensure that green hydrogen production can start immediately, European Union Commission President Ursula von der Leyen in her state of the union address announced the creation of a new European Hydrogen Bank.
  • Nicholas Wrigley, Chairman of First Hydrogen UK, said: "The European Union policy framework and commitment to hydrogen is now in place and represents a significant opportunity for First hydrogen's total solution business model of providing fleet vehicles and hydrogen as a service."
  • First Hydrogen Corp. is a Vancouver and London UK-based company focused on zero-emission vehicles, green hydrogen production and distribution and supercritical carbon dioxide extractor systems.

Assignar Kicks Off Expansion Plans with Launch into the UK Construction Market

Retrieved on: 
Wednesday, September 28, 2022

Assignar, the global leader in cloud-based construction operations software, today announces the expansion of its business operations into the United Kingdom.

Key Points: 
  • Assignar, the global leader in cloud-based construction operations software, today announces the expansion of its business operations into the United Kingdom.
  • The company is designed to bring all construction operations under a single view, making it particularly effective for highly regulated verticals.
  • Assignar was designed from a boots-on-the-ground perspective because its the solution I needed for my contracting company, explains Assignar CEO Sean McCreanor.
  • From my own experience, I know the UK market is more than ready for the tools offered in the Assignar platform.

Assignar Introduces New Platform Features to Improve Construction Operations

Retrieved on: 
Wednesday, September 7, 2022

Assignar, the global leader in cloud-based construction operations and management, today introduces its latest round of new platform features to make operations, scheduling and overall processes more streamlined and efficient.

Key Points: 
  • Assignar, the global leader in cloud-based construction operations and management, today introduces its latest round of new platform features to make operations, scheduling and overall processes more streamlined and efficient.
  • Our latest round of enhancements is informed by our deep understanding of customer needs and feedback on how we can further improve productivity and overall business operations within the Assignar platform.
  • The construction management software leader enables teams to run projects more efficiently and improve overall operations from day one.
  • Assignar continues to expand and evaluate its product roadmap to ensure its platform and offerings are enabling teams to optimize construction operations.

Green Web3 Company OneOf Closes Over $8M in Strategic Round With Participation From Amex Ventures, Mirabaud Lifestyle Impact & Innovation Fund and Other Funds

Retrieved on: 
Monday, August 1, 2022

Investors participating in the new round include Amex Ventures, Mirabaud Lifestyle Impact and Innovation Fund, Snow Hill Ventures, Sangha Capital, Chain Link Crypto Fund and others.

Key Points: 
  • Investors participating in the new round include Amex Ventures, Mirabaud Lifestyle Impact and Innovation Fund, Snow Hill Ventures, Sangha Capital, Chain Link Crypto Fund and others.
  • The new capital infusion brings OneOfs total funding to-date to over $72M raised.
  • Existing investors include famed environmentalist and VC Bill Tais Actai Unicorn Fund, Galaxy Digital, Nima Capital, Sangha Capital, Recharge Capital, Andromeda Capital, Sanctor Capital, Tezos Foundation and others.
  • OneOf is launching a set of NFTs accessible to American Express Card Members as part of an event hosted by American Express.